The Benchmark Company
New York City, New Yorkbenchmarkcompany.com
Overview
The Benchmark Company is a full-service investment banking firm offering a robust sales and trading platform, award-winning equity research, and a highly experienced investment banking team. The firm provides corporate finance and capital market advice related to initial public offerings, mergers and acquisitions, special situations, recapitalizations, divestitures, and private placement transactions. The Benchmark Company caters to consumer products services, business products services, financial services, healthcare, and information technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vida | Apr 2026 | IPO | Lead |
| BioVentrix | Feb 2026 | IPO | Lead |
| Gloo Holdings, Inc. | Nov 2025 | IPO | Co-investor |
| CapsoVision | Jul 2025 | IPO | Lead |
| Everfront Biotech Inc. | Jan 2025 | IPO | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
